Skip to main content
. 2020 Jan 21;10:766. doi: 10.1038/s41598-020-57698-0

Figure 5.

Figure 5

A schematic model depicting SENP2 role in bortezomib resistance development in MM: SENP2 loss of expression results in increased IkBa sumoylation that consequently leads to the activation of NF-κB, which potentiates bortezomib resistance development in MM.